The US Food and Drug Administration’s anesthesiology and respiratory therapy devices advisory committee agreed that pulse oximeters with decreased accuracy on patients with dark skin is a problem that comes with clinical implications.
FDA Advisory Panel Agrees Pulse Oximeter Skin Pigment Discrepancies Pose Clinical Threat
The FDA’s Anesthesiology and Respiratory Therapy Devices advisory panel met to discuss racial and skin-pigmentation bias in pulse oximeter devices as well as recommendations for the agency.
